Company Email Format Management

iX Biopharma

Pharmaceutical Manufacturing Au 11 employees

Employees: 11
Contacts: 2
Emails: 2
Phones: 1

ixbiopharma.com LinkedIn

iX Biopharma Overview

Headquarters: Au
Phone Number: Available in AeroLeads
Website: ixbiopharma.com
Industry: Pharmaceutical Manufacturing
Employees: 11
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Patented Sublingual Drug Delivery Technology Novel Drug Delivery Systems Pain Management Therapies for diseases of the central nervous system

About iX Biopharma

iX Biopharma is a listed, specialty pharmaceutical and nutraceutical company focusing on the development and commercialisation of therapies for diseases of the central nervous system using novel, patent-protected formulations for sublingual delivery. iX Biopharma’s pipeline of products under development includes Wafermine (ketamine wafer) and BnoX (buprenorphine wafer) for pain management. iX Biopharma’s drugs for the treatment of erectile dysfunction, Wafesil, a sublingual sildenafil wafer, and Silcap, have been registered in Australia. iX Biopharma has developed Xativa, the world’s first freeze-dried sublingual medicinal cannabis wafer. The Group’s nutraceuticals division, Entity Health Limited, is engaged in the development and commercialisation of nutraceutical products. Subsidiaries: iX Syrinx ( https://www.ixsyrinx.com ) Entity health ( https://www.entity-health.com )

iX Biopharma Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

iX Biopharma Org Chart

Sample employees and titles

Name	Title	Location	Contact
Bertram Khoo	Business Development, Pharmaceuticals		View
Janakan Krishnarajah	Chief Operating Officer and Chief	Singapore	Email Phone
Patrick Davies		Greater Melbourne Area, Australia	Email
Siew Xuan Chui	Inhouse Legal Counsel		View